Biotechnology Industry Immersion
Biotechnology has been a disruptive technology in the life sciences industry, especially in biomedical therapeutics and diagnostics. Continued success in the biotechnology industry requires the application of extraordinary leadership and management skills in addition to the scientific innovations.
video: Learning how biotech execs Lead & Manage
- Curriculum designed by both UC Davis faculty and industry executives to reflect the latest challenges in the industry
- Gain hands-on experience each week, teaming with MBA and biotech sciences students in problem-solving sessions
- Five weeks of interactive classes on Fridays in Winter Quarter taught by senior executives from a select group of companies
- Group assignments in every class, examining potential solutions to management challenges
- Scholarships ranging from $3,000 to $42,000 are available to incoming MBA admits for fall 2020
This course introduces students to the many facets of the biotechnology industry and provides a framework for understanding the complex forces that shape and drive it.
You’ll learn from top industry executives through live cases about:
- Growth and new developments
- Drug innovations
- Drug regulations
- Marketing and commercialization
“Most MBA programs leverage cases to help bring texture to business concepts, but the Immersion program brings cases to life and lets you experience them.” – David Bodimer MBA 19
2020 Executive Speakers
Lonnie Bookbinder, Ph.D., MBA, Founder and CEO, ARIZ Precision Medicine
- Robert Bottome, Executive Director, Global Supply Chain, BioMarin Pharmaceutical, Inc.
- Seema Kantak, Ph.D., Executive Director, Biologics & Biotherapeutics, Exelixis, Inc.
- Anna Marie Tuazon, Ph.D., Manager, Regulatory Affairs, Gilead Sciences, Inc.
- Craig Shimasaki, Ph.D., MBA, President and CEO, Moleculera Labs and BioSource Consulting
- Tracy Brockman Shafizadeh, Ph.D., Director, Scientific Communications, Evolve BioSystems, Inc.
- Samara Freeman, Ph.D., Director of Regulatory Affairs and Intellectual Property, Evolve BioSystems, Inc.
- Steve Chamow, Ph.D., Principal, Chamow and Associates
- Kristen Beck, Ph.D., Staff Scientist, Research Staff Member, Industrial and Applied Genomics, IBM Research-Almaden
- Vivien Chan, Ph.D., Chief Operating Officer, Eureka Therapeutics, Inc.
“It’s a fantastic opportunity for students to get some knowledge and classroom learning about the intersection between business, academia and biotechnology,” – Christopher Murriel, OncoMed Pharmaceuticals